Lysophosphatidylcholine induces arachidonic acid release and calcium overload in cardiac myoblastic H9c2 cells

Journal of Lipid Research

Volumn 40, Issue 10, 1999, Pages 1818-1826

  Golfman, Leonard S ^a   Haughey, Norman J ^b   Wong, Jason T ^a   Jiang, Jenny Y ^a   Lee, Douglas ^a   Geiger, Jonathan D ^b   Choy, Patrick C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Calcium transport; Lysophospholipids; MAPK; Myoblasts; Myocardial ischemia; Phospholipase A2; PKC; Sarcolemma

Indexed keywords

ARACHIDONIC ACID; CALCIUM; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NIMODIPINE; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; HEART MUSCLE CELL; LIPID COMPOSITION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ANIMALS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CALCIUM; CELL LINE; ENZYME INHIBITORS; FLAVONOIDS; INDOLES; ISOQUINOLINES; KINETICS; LYSOPHOSPHATIDYLCHOLINES; MYOCARDIUM; NIMODIPINE; PHOSPHOLIPASES A; PROTEIN KINASE C; RATS; STAUROSPORINE; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 0032878532     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Waite, M. 1991. Phospholipases. In Biochemistry of Lipids, Lipoproteins and Membranes. D. E. Vance and J. E. Vance, editors, Elsevier Science Publishers, Amsterdam. 269-296.
2. 2(s): comparison of arachidonoyl-selective and non-selective enzymes. FASEB. J. 7: 339-348.
3. 2. J. Biol. Chem. 272: 16709-16712.
4. 2. J. Biol. Chem. 272: 16069-16072.
5. 2. J. Biol. Chem. 269: 13057-13060.
6. 2. J. Lipid. Mediat. Cell Signal. 12: 83-117.
7. 2. Biochim. Biophys. Acta. 1170: 217-231.
8. 2. J. Biol. Chem. 266: 14850-14853.
9. 2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22: 1-2.
10. Weltzien, H. U. 1979. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochem. Biophys. Acta. 559: 259-287.
11. Giffin, M. D., G. Arthur, P. C. Choy, and R. Y. K. Man 1988. Lysophosphatidylcholine metabolism and cardiac arrhythmias. Can. J. Physiol. Pharmacol. 66: 185-189
12. Choy, P., and G. Arthur. 1989. Phosphatidylcholine biosynthesis from lysophosphatidylcholine. In Phosphatidylcholine Metabolism. D. Vance, editor. CRC Press, Boca Raton, FL. Chapter 6.
13. Choy, P., M. Skrzypczak, D. Lee, and F. T. Jay. 1997. Acyl-GPC and alkenyl/alkyl-GPC:acyl-CoA acyltransferases. Biochem. Biophys. Acta. 1348: 124-133.
14. Sobel, B. E., P. B. Corr, A. K. Robinson, R. A. Goldstein, F. X. Witkowski, and M. S. Klein. 1978. Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J. Clin. Invest. 62: 546-553.
15. Man, R. Y. K., T. L. Slater, M. P. J. Pelletier, and P. C. Choy. 1983. Alterations of phospholipids in ischemic canine myocardium during acute arrythmias. Lipids. 18: 677-681.
16. Datorre, S. D., M. H. Creer, S. M. Pogwizd, and P. B. Corr. 1991. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J. Mol. Cell. Cardiol. 23 (Suppl. 1): 11-22.
17. + exchange inhibition protects against mechanical, ultrastructural, and biochemical impairment induced by low concentrations of lysophosphatidylcholine in isolated rat hearts. Circ. Res. 80: 95-102.
18. Woodley, S. L., H. Ikenouchi, and W. H. Barry. 1991. Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma. J. Mol. Cell. Cardiol. 23: 671-680.
19. 2+-overload in isolated cardiomyocytes and effect of cytoprotective drugs. J. Mol. Cell. Cardiol. 24: 977-988.
20. Yu, L., T. Netticadan, Y-J. Xu, V. Panagia, and N. S. Dhalla. 1998. Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes. J. Pharmacol. Exp. Ther. 286: 1-8.
21. 2+ exchange activity by lysophosphatidylcholine and palmitoylcarnitine. Cardiovasc. Pathobiol. 2: 181-185.
22. Ahumada, G. C., S. R. Bergmann, E. Carlson, P. B. Corr, and B. E. Sobel. 1979. Augmentation of cyclic AMP content induced by lysophosphatidylcholine in rabbit hearts. Cardiovasc. Res. 13: 377-382.
23. Watanabe, A. M., and H. R. Besch, Jr. 1974. Cyclic adenosine monophosphate modulation of slow calcium influx channels in guinea pig hearts. Circ. Res. 35: 316-318.
24. Phillips, G. B. 1957. The isolation of lysolecithin from human serum. Proc. Natl. Acad. Sci. USA. 43: 566-570.
25. Portman, O. W., and M. Alexander. 1969. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J. Lipid Res. 10: 158-165.
26. Steinberg, D., S. Parthasarathy, T. E. Carew, and J. C. Khoo. 1989. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
27. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low-density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
28. Kume, K., M. I. Cybulsky, and M. A. Gimbrone, Jr. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90: 1138-1144.
29. Kume, N., and M. A. Gimbrone. 1994. Lysophosphatidylcholine tracscriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93: 907-911.
30. Saito, T., A. Wolf, N. K. Menon, M. Saeed, and R. J. Bing. 1988. Lysolecithins as endothelium-dependent vascular smooth muscle relaxants that differ from endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA. 85: 8246-8250.
31. McMurray, H. F., S. Parthasarathy, and D. Steinberg. 1993. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 92: 1004-1008.
32. Quinn, M. T., S. Parthasarathy, and D. Steinberg. 1988. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA. 85: 2805-2809.
33. Dennis, E. A. 1987. The regulation of eicosanoid production: role of phospholipases and inhibitors. Biol. Technol. 5: 1294-1299.
34. Kimes, B. W., and B. L. Brandt. 1976. Properties of a clonal muscle cell line from rat heart. Exp. Cell Res. 98: 367-381.
35. Wong, J. T., K. Tran, G. N. Pierce, A. C. Chan, K. O, and P. C. Choy. 1998. Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells. J. Biol. Chem. 273: 6830-6836.
36. 2 is phosphorylated and activated by MAP kinase. Cell. 72: 269-278.
37. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
38. 2. J. Biol. Chem. 269: 19480-19487.
39. 2+-dependent protein kinase. Biochem. Biophys. Res. Commun. 135: 397-402.
40. Nixon, J. S., J. Bishop, D. Bradshaw, P. D. Davis, C. H. Hill, L. H. Elliot, H. Kumar, G. Lawton, E. J. Lewis, M. Mulqueen, D. Westmacott, J. Wadsworth, and S. E. Wilkinson. 1992. The design and biological properties of potent and selective inhibitors of protein kinase C. Biochem. Soc. Trans. 20: 419-425.
41. Gekeler, V., R. Boer, F. Uberall, W. Ise, C. Schubert, I. Utz, J. Hofmann, K. H. Sanders, C. Schachtele, K. Klemm, and H. Grunicke. 1996. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on p-glycoprotein-mediated multidrug resistance. Br. J. Cancer. 74: 897-905.
42. Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. 1990. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265: 5267-5272.
43. Alessi, D. R., A. Cuenda, P. Cohen, D. J. Dudley, and A. R. Saltiel. 1995. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270: 27489-27494.
44. 2+-independent catalytic domain. J. Biol. Chem. 269: 18239-18249.
45. Okita, M., D. C. Gaudette, G. B. Mills, and B. J. Holub. 1997. Elevated levels and altered fatty acid composition of plasma lysophosphotidylcholine (lysoPC) in ovarian cancer patients. Int. J. Cancer. 71: 31-34.
46. 2 with membrane in the macrophage cell line RAW 264.7. J. Biol. Chem. 265: 5409-5413.
47. 2+ homeostasis in cardiomyocytes. Mol. Cell Biochem. 172: 149-157.
48. Seger, R., and E. G. Krebs. 1995. The MAPK signalling cascade. FASEB. J. 9: 726-735.
49. A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268: 1960-1964.